Literature DB >> 23733760

Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis.

Nobuaki Ochi1, Hiromichi Yamane, Tomoko Yamagishi, Yasumasa Monobe, Nagio Takigawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23733760     DOI: 10.1200/JCO.2012.46.2770

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder.

Authors:  Christopher Melani; Elaine S Jaffe; Wyndham H Wilson
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

2.  A surgical case of methotrexate-associated lymphomatoid granuloma.

Authors:  Hajime Watanabe; Ryota Masuda; Tomohiko Matsuzaki; Rurika Hamanaka; Yoichiro Ikoma; Takayuki Nakano; Kana Oiwa; Mitsutomo Kohno; Masayuki Iwazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-12-19

Review 3.  The Spontaneous Regression of Grade 3 Methotrexate-related Lymphomatoid Granulomatosis: A Case Report and Literature Review.

Authors:  Naoto Aiko; Akimasa Sekine; Shigeaki Umeda; Takuma Katano; Goshi Matama; Kohsuke Isomoto; Ryota Otoshi; Takashi Ogura
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

Review 4.  Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder.

Authors:  Tatsuyoshi Ikeue; Hiroaki Kawachi; Hiroshi Yoshida; Eiichiro Tanaka; Susumu Noguchi; Akari Fukao; Satoshi Terashita; Tomoko Tajiri; Sadao Horikawa; Takakazu Sugita
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

5.  Simultaneous Presentation of Lymphomatoid Granulomatosis and Multiple myeloma in an Immunodeficient Patient with Rheumatoid Arthritis.

Authors:  Shin Lee; Eiju Negoro; Hisashi Oki; Yoshiaki Imamura; Takahiro Yamauchi
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

6.  The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).

Authors:  Shiro Watanabe; Osamu Manabe; Kenji Hirata; Noriko Oyama-Manabe; Naoya Hattori; Yasuka Kikuchi; Kentaro Kobayashi; Takuya Toyonaga; Nagara Tamaki
Journal:  BMC Cancer       Date:  2016-08-15       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.